Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
BRCA2 deletion
i
Other names:
BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset
Associations
(10)
News
Trials
B | Sensitive
C3 | Sensitive
C4 | Sensitive
D | Sensitive
B | Resistant
C3 | Resistant
C4 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Hormone Therapy
PARP Inhibitors
Tyrosine Kinase Inhibitors
Chemotherapy
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Cancel
Prostate Cancer
Ovarian Cancer
Ovarian Serous Adenocarcinoma
Squamous Cell Skin Cancer
Soft Tissue Sarcoma
abiraterone acetate
B
BRCA2 deletion
|
Prostate Cancer
|
abiraterone acetate
enzalutamide capsule
B
BRCA2 deletion
|
Prostate Cancer
|
enzalutamide capsule
rucaparib
C3
BRCA2 deletion
|
Prostate Cancer
|
rucaparib
C3
BRCA2 deletion
|
Ovarian Cancer
|
rucaparib
bevacizumab
C3
BRCA2 deletion
|
Ovarian Cancer
|
bevacizumab
C3
BRCA2 deletion
|
Ovarian Serous Adenocarcinoma
|
bevacizumab
pembrolizumab
C4
BRCA2 deletion
|
Squamous Cell Skin Cancer
|
pembrolizumab
olaparib
C3
BRCA2 deletion
|
Prostate Cancer
|
olaparib
ACR-368
D
BRCA2 deletion
|
Prostate Cancer
|
ACR-368
ifosfamide + pegylated liposomal doxorubicin
C3
BRCA2 deletion
|
Soft Tissue Sarcoma
|
ifosfamide + pegylated liposomal doxorubicin
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
